| 0 (0%) | 12-05 10:02 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.48 |
1-year : | 1.66 |
| Resists | First : | 1.26 |
Second : | 1.42 |
| Pivot price | 1.15 | |||
| Supports | First : | 1 | Second : | 0.84 |
| MAs | MA(5) : | 1.16 |
MA(20) : | 1.18 |
| MA(100) : | 1.38 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1  |
Signal : | -0.1 |
| %K %D | K(14,3) : | 66.6 |
D(3) : | 59.3 |
| RSI | RSI(14): 44.3 |
|||
| 52-week | High : | 3.79 | Low : | 0.65 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ HOTH ] has closed below upper band by 38.3%. Bollinger Bands are 50% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.21 - 1.22 | 1.22 - 1.22 |
| Low: | 1.16 - 1.16 | 1.16 - 1.17 |
| Close: | 1.18 - 1.19 | 1.19 - 1.2 |
Wed, 03 Dec 2025
Hoth Therapeutics stock rises after pipeline update - Investing.com
Tue, 02 Dec 2025
SWG Legends previews the Bespin revitalization, PvP content, Hoth revamp, and Life Day 2025 - Massively Overpowered
Mon, 01 Dec 2025
Hoth Therapeutics to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference, December 2-3, 2025 - Eastern Progress
Thu, 20 Nov 2025
Hoth Therapeutics Accepted Into NVIDIA Connect Program, Expanding Its AI and Accelerated Computing Capabilities - PR Newswire
Tue, 21 Oct 2025
Hoth Therapeutics Reports FDA Orphan Drug Designation and Strong Preclinical Data for HT-KIT in Rare c-KIT-Driven Cancers - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 16 (M) |
| Shares Float | 15 (M) |
| Held by Insiders | 3.5 (%) |
| Held by Institutions | 8 (%) |
| Shares Short | 526 (K) |
| Shares Short P.Month | 413 (K) |
| EPS | -1.02 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.54 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -84.5 % |
| Return on Equity (ttm) | -151.2 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -10 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -1.16 |
| PEG Ratio | 0 |
| Price to Book value | 2.18 |
| Price to Sales | 0 |
| Price to Cash Flow | -1.9 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|